Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wave 80 Biosciences has developed advanced sample prep and diagnostic assay technologies for infectious and autoimmune diseases. Their semi‑quantitative HIV viral load assay is moving toward full-scale clinical trials. The company’s platforms are designed to automate complex sample processing steps and deliver high sensitivity in challenging matrices like sputum or blood. They have received NIH SBIR funding for rapid chlamydia testing in low-resource settings. Some products are being prepared for global health markets with distribution through organizations such as PEPFAR and the Clinton Foundation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wave 80 Biosciences.